Transforming personal health.

Phase

Awarded

Transforming personal health.

$2.25 Million

Prize Purse

The $2.25 million Nokia Sensing XCHALLENGE aimed to stimulate the development of a new generation of health sensors and sensing technologies that can drastically improve the quality, accuracy and ease of monitoring a person’s health. Improvements in these technologies will empower individuals to effortlessly monitor and collect their own real-time health data, providing both consumers and healthcare providers convenient access to critical information whenever and wherever they need it.

Prize Purse

  • A prize purse of $1.125 million was available for each of the two Competitions, for a total of $2.25 million. Each competition offered up to six awards:
  • A $525,000 Grand Prize
  • Up to five Distinguished Awards of $120,000 each

The Grand Challenge

The inefficiencies and total cost of the U.S. healthcare system (and healthcare systems around the globe) has been a pressing social and political issue for many years.

In the U.S., the total spent annually on the healthcare system is more than $2 trillion, which accounts for more than 15 percent of the nation’s gross domestic product. Health sensors have the capacity to stem this trend. Consumer use of sensors and sensing solutions has the potential to improve, extend and ease delivery of healthcare services, as well as reduce costs to the benefit of health providers and patients.

Summary Video

How They Won

Teams were challenged to create sensing technology developed for any of the principal medical sensing domains, including:
Biosensors - Environmental Kinematics
Imaging - Behavioral Psychology

Teams

67 Registered Teams
23 Finalists
(both competitions)

Impact

  • • Over $105 million invested in NSXC winning teams
  • • 6 new patents issued to winning teams 
  • • Winning teams have established partnerships with NASA and USAF
  • • Winning teams have commenced multiple clinical trials, including the world’s largest breath-based clinical trial for early cancer detection
  • • Commercial launch of Cordella Heart Failure System (Q3 2018)
  • • Launch of Owlstone Breath Biopsy Kits
  • • Environ selected as supplier to the government of Singapore with large B2G contract
  • • NIH grants for POC tests for drug resistant TB and HPV 

Prize Activity